ofa tirzepatide F.D.A. Approves New Obesity Drug That Will Compete With Wegovy UPDATE [March 7, 2025]: OFA

In the UK, the Medicines and Healthcare products Regulatory Agency (MHRA) has licensed these medications for specific uses, usually involving the management of type 2 diabetes or as a support for weight loss in individuals with a high BMI and weight-related health complications

With food dysfunction: You flood the reward system with artificial dopamine hits receptors downregulate you need more food to feel anything meanwhile, non-food joys get quieter and quieter

In a major trial, patients using Zepbound lost an average of 20% of their body weight, while those using Semaglutide GLP-1 lost about 14%

Your doctor will assess your skin and determine the right whitening method for your skin type